Overview

Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke

Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of autologous peripheral hematopoietic stem cell transplantation in ischemic stroke.
Phase:
Phase 1
Details
Lead Sponsor:
Zhejiang Hospital
Collaborator:
Zhejiang University
Treatments:
Antipyrine
Aspirin
Atorvastatin
Atorvastatin Calcium
Edaravone
Phenylmethylpyrazolone
Warfarin